Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - metformin hydrochloride, quantity: 500 mg; ertugliflozin pyroglutamic acid, quantity: 3.238 mg (equivalent: ertugliflozin, qty 2.5 mg) - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; carnauba wax; povidone; microcrystalline cellulose; sodium lauryl sulfate; titanium dioxide; hypromellose; hyprolose; iron oxide red - segluromet (ertugliflozin and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and metformin is appropriate [see 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration]

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg; ertugliflozin pyroglutamic acid, quantity: 9.713 mg (equivalent: ertugliflozin, qty 7.5 mg) - tablet, film coated - excipient ingredients: povidone; crospovidone; sodium lauryl sulfate; carnauba wax; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; hyprolose; iron oxide red - segluromet (ertugliflozin and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and metformin is appropriate [see 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration]

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - metformin hydrochloride, quantity: 1000 mg; ertugliflozin pyroglutamic acid, quantity: 3.238 mg (equivalent: ertugliflozin, qty 2.5 mg) - tablet, film coated - excipient ingredients: povidone; sodium lauryl sulfate; magnesium stearate; crospovidone; microcrystalline cellulose; carnauba wax; titanium dioxide; hypromellose; hyprolose; iron oxide red - segluromet (ertugliflozin and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and metformin is appropriate [see 5.1 pharmacodynamic properties, clinical trials and 4.2 dose and method of administration]

Canada - English - Health Canada

merck canada inc - ertugliflozin - tablet - 5mg - ertugliflozin 5mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Canada - English - Health Canada

merck canada inc - ertugliflozin - tablet - 15mg - ertugliflozin 15mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - ertugliflozin l-pyroglutamic acid -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - ertugliflozin l-pyroglutamic acid -

Canada - English - Health Canada

merck canada inc - ertugliflozin; sitagliptin (sitagliptin phosphate) - tablet - 5mg; 100mg - ertugliflozin 5mg; sitagliptin (sitagliptin phosphate) 100mg - dipeptidyl peptidase-4 (dpp-4) inhibitors

Canada - English - Health Canada

merck canada inc - ertugliflozin; sitagliptin (sitagliptin phosphate) - tablet - 15mg; 100mg - ertugliflozin 15mg; sitagliptin (sitagliptin phosphate) 100mg - dipeptidyl peptidase-4 (dpp-4) inhibitors

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - ertugliflozin 5 mg/1 tab - 5 mg/1 tab